Verily

Better health, lower costs with GLP-1s is possible. Register for a live webinar on April 30th to learn Verily’s approach to better GLP-1 outcomes: https://veri.ly/4hUGrUD Speakers include Verily's David Burdick and Sarah Thompson, Heidi Guetzkow of Aon and moderator Lydia Ramsey Pflanzer of Endpoints News. #GLP1 #MetabolicHealth #ChronicCare

Now that we’re well into spring, is it safe to say that flu season is behind us? We took a look at this past winter’s data from Verily Sightline wastewater monitoring program and found 3 insightful trends: 🦠 Respiratory viruses are on the decline, but the season isn’t over. 📈 Prevalence of norovirus remains high. ⚠️ H5N1 is still not a concern for humans, but officials remain on alert. Get a detailed view of the data: https://veri.ly/4lomrwM #NPHW #PublicHealth #wastewater #RSV

Wastewater epidemiology is transforming how we detect and respond to the spread of viruses. This #PublicHealthWeek, take time to learn the basics – how it was born, what wastewater is, and the work Verily scientists are doing to successfully track a variety of infectious diseases. https://veri.ly/3FZJhKT #NPHW #wastewater #PublicHealth #HealthInnovation

Retina specialist Peter Karth, MD, MBA, FASRS, FACS integrated the Verily Numetric Retinal Camera into his practice. It has helped him ensure that more patients are screened, referred, and treated for retinal diseases early, ultimately preserving their vision. Learn how: https://lnkd.in/dppxTduB #EyeHealth #HealthTech

GLP-1s can be transformative for weight loss, but only with the right support. Our team at Verily will be hosting a webinar on April 30th about how Verily Lightpath is uniquely positioned to deliver data-driven, comprehensive clinical care that can help optimize outcomes and costs related to GLP-1 medications. This is going to be a great discussion with Verily experts David Burdick and Sarah Thompson, Heidi Guetzkow of Aon, and moderator Lydia Ramsey Pflanzer of Endpoints News. If you’re interested in hearing more about unlocking the potential of GLP-1s, register here: https://lnkd.in/gwXRYRCt

💓 Traditionally, resting heart rate (RHR) is determined through clinical measurements during physical exams or electrocardiography (ECG). New research published in JMIR Publications found that RHR can be measured easily and accurately using a wearable device, specifically the Verily Study Watch, within a large, heterogeneous cohort. Participants of the study were part of the Project Baseline Health Study, a collaboration with Verily, Duke Clinical and Translational Science Institute and Stanford University School of Medicine. Read the results: https://lnkd.in/dcNnSrkq #wearables #ClinicalResearch

GLP-1 accessibility and achieving lasting, meaningful clinical outcomes are major challenges for the healthcare ecosystem. In a new blog, Dr. Vindell Washington breaks down how the clinical implications are considered in the design of Verily Lightpath* — our personalized, AI-powered chronic-care solution — to directly address these challenges. https://veri.ly/42ewStQ If you want to dive deeper into how Verily Lightpath can support payer and employer populations with GLP-1 management, register for our webinar on April 30: https://veri.ly/4hUGrUD #PrecisionHealth #AIInHealthcare #DiabetesManagement *To be available in 2026

Exciting to see Verily Sightline, our public health monitoring solution, featured on NBC Bay Area!  Data from San Francisco and San Jose wastewater plants reveal that Influenza A is declining, but Influenza B has spiked, highlighting the power of real-time public health insights. According to Verily’s Amy Lockwood, the innovation allows us to track pathogens efficiently, moving beyond traditional methods that rely on individual doctor visits. https://lnkd.in/ddputiGG If you have Spring Break travel plans, be sure to check out our wastewater tracker before you head to your destination! https://veri.ly/42pvrtV #wastewater #PublicHealth #InfluenzaA #InfluenzaB

Imagine #AI as a personalized guide for each patient, offering support, anticipating needs, and adjusting in real time. While healthcare engagement is a common topic, digital tools often fall short. AI and personalized data offer great potential, yet many organizations face low adoption. At ViVE last month in Nashville, Erich S. Huang, MD, PhD of Verily discusses the future of AI in healthcare, including patient engagement, automation versus human interaction, and Verily's Lightpath platform for chronic care management. https://lnkd.in/gZ5bruwg #AI #precisionhealth #patientengagement #chronicdiseasemanagement #diabetes #CVD #obesity #healthtech #digitalhealth

We invite you to meet Verily experts at one of our upcoming events to hear how we’re making healthcare more personal and precise. 📍 Boston, MA - Bio-IT World Conference, April 2-4 📍 New York, NY - The Conference Board Employee Health Care Conference, April 8-9  📍 Nashville, TN - Business Group on Health 2025 Annual Conference, April 22-24  📍 New Orleans, LA - ACRP - Association of Clinical Research Professionals 2025, April 24-27  📍 San Antonio, TX - NACCHO 2025 Preparedness Summit, April 29 - May 2 Subscribe to our newsletter to know where to find us next and the latest Verily news: https://veri.ly/3XBc9PG #PrecisionHealth #HealthTech #HealthInnovation